Proteomic meta-study harmonization, mechanotyping and drug repurposing candidate prediction with ProHarMeD

Proteomics technologies, which include a diverse range of approaches such as mass spectrometry-based, array-based, and others, are key technologies for the identification of biomarkers and disease mechanisms, referred to as mechanotyping. Despite over 15,000 published studies in 2022 alone, leveragi...

Descripción completa

Detalles Bibliográficos
Autores principales: Adamowicz, Klaudia, Arend, Lis, Maier, Andreas, Schmidt, Johannes R., Kuster, Bernhard, Tsoy, Olga, Zolotareva, Olga, Baumbach, Jan, Laske, Tanja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564802/
https://www.ncbi.nlm.nih.gov/pubmed/37816770
http://dx.doi.org/10.1038/s41540-023-00311-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564802/
https://www.ncbi.nlm.nih.gov/pubmed/37816770
http://dx.doi.org/10.1038/s41540-023-00311-7

Ejemplares similares